Skip to content
sellNotable cluster of 10

Julie Smith sold $2.8M of EXEL

director at EXELIXIS, INC.. 73,808 shares at an average of $38.00, traded Feb 27, 2025, filed Feb 28, 2025.

Warning score
60
Value
$2.8M
73,808 shares
Holdings after
10,778
-113% from before
From 52-week low
+48%
low $25.39, close $37.65
From 52-week high
0%
high $37.65, as of Feb 27, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $2.8M at market
    +25
  • Share of holdings sold
    Sold 100% of holdings
    +20
  • Cluster
    10 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

EXELOct 9, 2026 · close 59.86
Since filing Feb 28, 2025: +54.7%SPY +33.6% · excess +21.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000939767-25-000045, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 27, 2025MOption exercise
Common Stock
+31,167$20.50$639k41,945Feb 28, 2025
Feb 27, 2025MOption exercise
Common Stock
+23,347$19.77$462k65,292Feb 28, 2025
Feb 27, 2025SOpen-market sale
Common Stock
-54,514$38.13$2.1M10,778Feb 28, 2025
Feb 28, 2025MOption exercise
Common Stock
+19,294$19.77$381k30,072Feb 28, 2025
Feb 28, 2025SOpen-market sale
Common Stock
-19,294$37.62$726k10,778Feb 28, 2025
Feb 27, 2025MOption exercise
Option (right to buy)derivative
-31,167$0.00$00Feb 28, 2025
Feb 27, 2025MOption exercise
Option (right to buy)derivative
-23,347$0.00$019,294Feb 28, 2025
Feb 28, 2025MOption exercise
Option (right to buy)derivative
-19,294$0.00$00Feb 28, 2025

Related signals

Other insiders at EXELIXIS, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
26Weak
EXELsell 610b5-1
EXELIXIS, INC.
Patrick J. Haley
EVP, Commercial
$388k
10,000 shares
-3%
10Weak
EXELsell 1010b5-1
EXELIXIS, INC.
Jack L Wyszomierski
director
$331k
8,768 shares
-2%
55Moderate
EXELsell 10
EXELIXIS, INC.
Dana Aftab
CSO/EVP Disc & Trans Research
$992k
26,987 shares
-5%
47Moderate
EXELsell 10
EXELIXIS, INC.
Christopher J. Senner
EVP and CFO
$1.1M
29,314 shares
-4%
46Moderate
EXELsell 10
EXELIXIS, INC.
Bob Oliver
director
$695k
18,647 shares
-36%
60Notable
EXELsell 10
EXELIXIS, INC.
Patrick J. Haley
EVP, Commercial
$1.9M
52,636 shares
-15%
42Moderate
EXELsell 10
EXELIXIS, INC.
Mary C Beckerle
director
$426k
12,210 shares
-29%
21Weak
EXELsell 1010b5-1
EXELIXIS, INC.
Sue Gail Eckhardt
director
$405k
11,568 shares
-28%
50Moderate
EXELsell 10
EXELIXIS, INC.
Maria C Freire
director
$1.5M
44,114 shares
-33%
34Weak
EXELsell 10
EXELIXIS, INC.
George Poste
director
$551k
15,874 shares
-9%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Julie Smith sold $2.8M of EXEL | InsiderTell